Creon - Pancrelipase
Navigation: NDC > Supplier starting with: A > ATLANTIC BIOLOGICALS CORPS| Field | Value |
|---|---|
| NDC Code: | 17856-1224 |
| Proprietary Name: | Creon |
| Suffix: | |
| Non-Proprietary Name: | Pancrelipase |
| Dosage Form: | CAPSULE, DELAYED RELEASE PELLETS |
| Method: | ORAL |
| Original Marketing Date: | 13-08-2010 |
| Category Name: | NDA |
| Application Number: | NDA020725 |
| Labeler: | ATLANTIC BIOLOGICALS CORPS |
| Substance Name: | PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE |
| Active Numerator Strength: | 120000; 24000; 76000 |
| Active Ingredient Unit: | [USP'U]/1; [USP'U]/1; [USP'U]/1 |
| Pharm Classes: | |
| DEA Schedule: |